American Oriental Bioengineering, Inc. (AOBI)
OTCMKTS
· Delayed Price · Currency is USD
0.0012
+0.0001 (9.09%)
At close: Oct 20, 2025
AOBI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | 2003 - 2007 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '13 Sep 30, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | 2003 - 2007 |
| Revenue | 121.58 | 145.1 | 212.69 | 305.94 | 296.15 | 264.64 | Upgrade
|
| Revenue Growth (YoY) | -10.20% | -31.78% | -30.48% | 3.31% | 11.91% | 64.91% | Upgrade
|
| Cost of Revenue | 84.32 | 100.74 | 112.94 | 148.19 | 129.37 | 91.03 | Upgrade
|
| Gross Profit | 37.26 | 44.36 | 99.75 | 157.76 | 166.78 | 173.61 | Upgrade
|
| Selling, General & Admin | 64.02 | 78.75 | 66.26 | 105.36 | 94.06 | 91.95 | Upgrade
|
| Research & Development | 7.64 | 6.25 | 12.66 | 15.37 | 7.92 | 1.53 | Upgrade
|
| Operating Expenses | 84.04 | 99.33 | 102.04 | 127.39 | 108.02 | 97.86 | Upgrade
|
| Operating Income | -46.78 | -54.97 | -2.29 | 30.37 | 58.76 | 75.75 | Upgrade
|
| Interest Expense | -3.52 | -5.83 | -6.61 | -5.9 | -5.75 | -2.57 | Upgrade
|
| Earnings From Equity Investments | -4.04 | -2.81 | -1.25 | 0.21 | 2.08 | -1.13 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.07 | 0.38 | 0.27 | -0.2 | -0.57 | -0.07 | Upgrade
|
| EBT Excluding Unusual Items | -54.27 | -63.24 | -9.89 | 24.48 | 54.52 | 71.98 | Upgrade
|
| Impairment of Goodwill | - | - | -33.16 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -20.38 | -1.08 | - | - | Upgrade
|
| Asset Writedown | -31.36 | -31.36 | -7.66 | - | - | - | Upgrade
|
| Other Unusual Items | -3.31 | 37.1 | 3.24 | - | - | - | Upgrade
|
| Pretax Income | -88.94 | -57.5 | -67.86 | 23.39 | 54.52 | 59.72 | Upgrade
|
| Income Tax Expense | 2.09 | 2.22 | 0.64 | 9.34 | 13.22 | 12.64 | Upgrade
|
| Earnings From Continuing Operations | -91.04 | -59.73 | -68.49 | 14.06 | 41.3 | 47.09 | Upgrade
|
| Minority Interest in Earnings | 0.02 | 0.01 | 1.04 | 0.03 | 0.12 | -0.03 | Upgrade
|
| Net Income | -91.02 | -59.71 | -67.45 | 14.09 | 41.42 | 47.06 | Upgrade
|
| Net Income to Common | -91.02 | -59.71 | -67.45 | 14.09 | 41.42 | 47.06 | Upgrade
|
| Net Income Growth | - | - | - | -65.99% | -11.98% | 7.28% | Upgrade
|
| Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | -4.50% | 2.37% | -1.18% | -15.19% | 8.55% | 15.26% | Upgrade
|
| EPS (Basic) | -1243.22 | -781.07 | -903.15 | 188.68 | 556.26 | 616.36 | Upgrade
|
| EPS (Diluted) | -1243.22 | -781.56 | -903.15 | 185.37 | 530.63 | 610.56 | Upgrade
|
| EPS Growth | - | - | - | -65.07% | -13.09% | -0.11% | Upgrade
|
| Free Cash Flow | -55.68 | -68.63 | -19.92 | 1.96 | 15.68 | 1.67 | Upgrade
|
| Free Cash Flow Per Share | -760.55 | -897.66 | -266.70 | 25.98 | 175.96 | 20.40 | Upgrade
|
| Gross Margin | 30.65% | 30.57% | 46.90% | 51.56% | 56.32% | 65.60% | Upgrade
|
| Operating Margin | -38.47% | -37.89% | -1.08% | 9.93% | 19.84% | 28.62% | Upgrade
|
| Profit Margin | -74.86% | -41.15% | -31.71% | 4.60% | 13.99% | 17.78% | Upgrade
|
| Free Cash Flow Margin | -45.80% | -47.30% | -9.37% | 0.64% | 5.29% | 0.63% | Upgrade
|
| EBITDA | -34.62 | -42.94 | 10.18 | 43.07 | 71.2 | 85.67 | Upgrade
|
| EBITDA Margin | -28.47% | -29.60% | 4.79% | 14.08% | 24.04% | 32.37% | Upgrade
|
| D&A For EBITDA | 12.16 | 12.03 | 12.47 | 12.7 | 12.44 | 9.92 | Upgrade
|
| EBIT | -46.78 | -54.97 | -2.29 | 30.37 | 58.76 | 75.75 | Upgrade
|
| EBIT Margin | -38.47% | -37.89% | -1.08% | 9.93% | 19.84% | 28.62% | Upgrade
|
| Effective Tax Rate | - | - | - | 39.90% | 24.24% | 21.16% | Upgrade
|
| Advertising Expenses | - | 29.03 | 14.91 | 38.92 | 31.9 | 34.1 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.